Serial #98101694
LIVE

Serial Number

98101694

Owner

Crossbow Therapeutics, Inc.

Attorney

Michael R. Graif

Filing Date

Jul 25, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98101694 Trademark

Serial Number: 98101694

Serial #98101694 is a trademark filed by Crossbow Therapeutics, Inc. on July 25, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Crossbow Therapeutics, Inc. (25 trademarks)

1030 Massachusetts Avenue, Suite 210
Cambridge, MA 02138

Entity Type: 03

Trademark Details

Filing Date

July 25, 2023

Registration Date

Not Registered

Published for Opposition

May 7, 2024

Goods & Services

Consulting services in the field of biotechnology; consulting services in the field of pharmaceutical research and development; consulting services in the field of genetic science; consulting services in the field of pharmacogenetics; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of diagnosis and treatment of cancer and immunological diseases; medical and scientific research information in the field of cancer and immunological diseases; pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; research and development in the field of cancer and immunological diseases; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the field of cancer and immunological diseases; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 4, 2025 EXRA
SOU EXTENSION 3 GRANTED
Nov 3, 2025 EX3G
SOU EXTENSION 3 FILED
Nov 3, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 3, 2025 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 1, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 1, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 1, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 1, 2025 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
May 3, 2025 EX2G
SOU EXTENSION 2 FILED
May 2, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
May 2, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 17, 2025 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jul 23, 2024 EX1G
SOU EXTENSION 1 FILED
Jul 23, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 23, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 2, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 1, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 1, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 1, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 1, 2024 CNEA
ASSIGNED TO EXAMINER
Mar 26, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 25, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2023 NWOS
NEW APPLICATION ENTERED
Jul 28, 2023 NWAP